Vice President, Market Access

Reporting to the SVP, Product Strategy & Commercialization, CARGO Therapeutics is seeking a VP, Market Access to establish the function and execute the global Market Access strategy and plans for CARGO assets, including a comprehensive US launch strategy for our lead product candidate, CRG-022. The selected individual will collaborate with cross-functional leaders, including Medical Affairs, HEOR, Marketing, Sales, Legal, Compliance, Analytics, and others to drive pre-launch, launch, and post-launch strategies to ensure patient access to potentially life-saving therapies. They will be responsible for developing, implementing, and managing all aspects of US market access strategy and execution, including pricing, reimbursement, patient services, and engagement strategy across key customer segments. This individual will develop payer, provider, and patient engagement strategies to secure access for future patients.

The role is based in San Carlos, CA but may also be suitable for a Remote arrangement.

WHAT YOU'LL DO AT CARGO THERAPEUTICS

• Develop and drive the execution of CARGO's Market Access strategy and operations addressing payers, distributors, patients, hospital systems, access marketing, pricing, and contracting

• Provide co-stewardship of the Commercial function as a member of the Commercial Leadership team to build and advance CARGO's Commercial vision, talent development, capabilities, and operations

• Establish and execute the Market Access roadmap to support the success of CARGO's first commercial launch

• Partner with HEOR, Medical Affairs, and Marketing to develop product value propositions, evidence generation plans, messaging, and supporting economic analyses/models

• Build and foster relationships with the top-tier payer and key opinion leaders/experts and advocacy groups in close collaboration with Marketing, Medical Affairs, and policy-making organizations

• Partner with Commercial Planning and Operations to refine and manage the channel-based data flows necessary to understand the business, track key trends and performance metrics, and identify opportunities for continued improvement

• Recruit, lead, motivate, develop, and retain a team of highly skilled Market Access professionals

• Lead the development, execution and management of all patient service programs and support

• Monitor and assess US and EU policy and market access environment changes and analyze impact on CARGO portfolio; provide guidance to the Executive Team on emerging trends, market dynamics, and federal and state policy and implications for our business and patients

• Provide expert opinion on pricing and reimbursement for pipeline products and target product profiles to ensure our future therapies have a robust value proposition for payers and access decision-makers

• Partner with Legal and Compliance to ensure that programs are consistent with the latest laws, guidance, and corporate policies

THE RIGHT STUFF: Required Experience & Qualifications

• BS/BA degree in science, business, or related discipline with 15+ years' experience in market access or other commercial roles; MBA preferred

• 5+ years of experience leading market access strategy, key account management across key access stakeholders, field reimbursement, pricing, HEOR, and patient hub services, with a focus in oncology

• In-depth, hands-on experience, expertise, and relationships within the US payer landscape in both public and private segments; deep US global market access expertise required; EU global market access experience preferred

• Launch experience in high-value oncology therapies administered through the medical benefit

• Cell or gene therapy experience highly preferred

• Demonstrated leadership and accountability

• Strong judgment, prioritization, and decision-making skills, with understanding of broader context of corporate strategies

• Experience building and leading teams in high growth, fast paced environments

• Proven ability to lead and collaborate within cross-functional teams: listen to diverse perspectives, build consensus, navigate ambiguity, prioritize opportunities, make decisions, and manage/motivate self and others

• Strong track record of success at building and executing market access strategies and tactics

• Exceptional communication skills; equally effective in front of field teams as in front of Executive Leadership and Board of Directors

• Demonstrated strategic thinking, problem solving, analytical critical thinking and planning skills

• Ability to attract, retain, develop, and inspire a collaborative, high-impact Market Access team

• Experience working in an agile, small company environment preferred

PAY RANGE

The combined pay range for this role is $260,000 - $360,000. Title and salary will be based on our assessment of skills and experience relevant to our needs for the role.

ABOUT CARGO THERAPEUTICS

CARGO Therapeutics, Inc. is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. CARGO's programs, platform technologies, and manufacturing strategy are designed to directly address the limitations of approved cell therapies, including limited durability of effect, safety concerns and unreliable supply. CARGO is currently evaluating its lead program, CRG-022, an autologous CD22 chimeric antigen receptor (CAR) T-cell therapy candidate, in a potentially pivotal Phase 2 clinical trial in patients with large B-cell lymphoma (LBCL) whose disease relapsed or was refractory (R/R) to CD19 CAR T-cell therapy. CARGO also plans to evaluate CRG-022 in patients at earlier stages of disease, including LBCL and other hematologic malignancies. Beyond its lead program, CARGO is leveraging its proprietary cell engineering platform technologies to develop a pipeline of programs that incorporate multiple transgene therapeutic "cargo" designed to enhance CAR T-cell persistence and trafficking to tumor lesions, as well as to help safeguard against tumor resistance and T-cell exhaustion. CARGO's founders are pioneers and world-class experts in CAR T-cell therapy, and its team has significant experience and success developing, manufacturing, launching and commercializing oncology and cell therapy products. For more information, please visit the CARGO Therapeutics website at https://cargo-tx.com/.

Join us to help make a difference!

EEO & EMPLOYMENT ELIGIBILITY

CARGO Therapeutics, Inc. is committed to building a diverse, equitable, and inclusive company. We provide equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability, or veteran status. CARGO Therapeutics, Inc. also complies with all applicable national, state, and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification required of applicable law.

CARGO Therapeutics requires all new hires to be fully vaccinated against COVID-19 as of their start date. This requirement is a condition of employment at CARGO Therapeutics, and it applies regardless of whether the position is located at a CARGO Therapeutics site or is fully remote. If you are unable to receive the vaccine due to a disability or serious medical condition, or because it is prohibited because of your sincerely held religious beliefs, you will have an opportunity to request a reasonable accommodation.